Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Sanifit (Spain)
h-index: 16
Total citations: 745
Total papers: 52
Homepage:
https://www.sanifit.com
Recent papers from Sanifit (Spain)
Hexasodium Fytate (SNF472 or CSL525) Inhibits Ectopic Calcification in Various Pseudoxanthoma Elasticum and Calcinosis Cutis Animal Models
Pharmaceuticals · 2025
Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification
Frontiers in Pharmacology · 2024
Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview
Frontiers in Pharmacology · 2022
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis
Clinical Kidney Journal · 2021
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis
Clinical Journal of the American Society of Nephrology · 2021
A Novel Ex Vivo Model of Aortic Valve Calcification. A Preliminary Report
Frontiers in Pharmacology · 2020
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial
Kidney International Reports · 2020
A novel assay to measure calcification propensity: from laboratory to humans
Scientific Reports · 2020
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis
British Journal of Pharmacology · 2020
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis
Circulation · 2019
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification
Clinical Kidney Journal · 2019
SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification
Vascular Pharmacology · 2019
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis
Journal of Nephrology · 2019
A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients
British Journal of Clinical Pharmacology · 2019
First‐time‐in‐human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification
British Journal of Clinical Pharmacology · 2018
Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification
PLoS ONE · 2018
SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels
Journal of Nephrology · 2018
A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma
Scientific Reports · 2017
Plant phosphates, phytate and pathological calcifications in chronic kidney disease
Nefrología (English Edition) · 2017
Direct Covalent Grafting of Phytate to Titanium Surfaces through Ti–O–P Bonding Shows Bone Stimulating Surface Properties and Decreased Bacterial Adhesion
ACS Applied Materials & Interfaces · 2016